Therapy Market Research Reports & Industry Analysis

... . The West Nile Virus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for West Nile Virus Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

... . The Pseudomonas aeruginosa Pneumonia (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Pseudomonas aeruginosa Pneumonia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

... Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

... releases. The Atopic Dermatitis (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Atopic Dermatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

... releases. The Scar (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Scar and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

... . The Alpha%li%Antitrypsin Deficiency (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Alpha%li%Antitrypsin Deficiency and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced In Hepatomas or SDF1 or Pre B Cell Growth Stimulating Factor or CXCL12) development landscape Develop ...

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE Like Apoptotic Protease 6 or CASP9 or EC 3.4.22.62) development landscape Develop and ...

... Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

... Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

... Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) development landscape Develop and ...

... reviews key players involved in Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A (Serine/Threonine Kinase MNB or MNB/DYRK Protein Kinase or Dual specificity YAK1 Related Kinase or HP86 or Protein Kinase Minibrain Homolog or DYRK1A or EC 2.7.12.1) targeted therapeutics development with respective ...

... /Universities. It also reviews key players involved in E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like Protein or Inhibitor Of Apoptosis Protein 3 or X Linked Inhibitor Of Apoptosis Protein or XIAP or EC 6.3.2.) targeted therapeutics development with respective active ...

... releases. The Raynauds Disease (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Raynauds Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

... ) Japan Proton Therapy Reimbursement Scenario Proton Therapy Center Component Analysis Proton Therapy Clinical Trail Insight by Phase, Institute & Country Proton Therapy Market – Major Deals Key Market Drivers and Inhibitors of the Japan Proton Therapy Market ...

This report analyzes the worldwide markets for Testosterone Replacement Therapy (TRT) in US$ Million. The Global and US markets are further analyzed by the following Product Segments: ... , a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...

This report analyzes the Global market for Fibromyalgia Therapeutics in US$ Million. Annual estimates and forecasts are provided for the ... 2022. Also, a six-year historic analysis is provided for this market. Market data and analytics are derived from primary and secondary ...

This report analyzes the worldwide markets for Acute Heart Failure (AHF) Therapeutics in US$ Thousand. The report provides separate comprehensive analytics for the ... players such as - Bayer AG Bristol-Myers Squibb Company Cardiorentis AG CVie Therapeutics Limited Cytokinetics, Inc.

... how developers can differentiate their pipeline therapies in KOL Insight: Targeted Therapies in Asthma. Ten North American and European KOLs provide their insight on 3 marketed products and ...

... releases. The Constipation (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Constipation and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

... releases. The Primary Biliary Cirrhosis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Primary Biliary Cirrhosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

... effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) development landscape Develop and design in-licensing ...

... . The Cluster Headache Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Cluster Headache Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development ...

... . The Encephalitis (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Encephalitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

This report analyzes the worldwide markets for Pulmonary Arterial Hypertension (PAH) Therapeutics in US$ Million. The Global market is analyzed by the following Drug Class ... Pharmaceuticals Ltd. Bayer AG Gilead Sciences, Inc. Pfizer, Inc. United Therapeutics Corporation

This report analyzes the worldwide markets for Peripheral Arterial Disease (PAD) Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, ... HealthCare Pharmaceuticals Bristol-Myers Squibb Company Merck & Co., Inc. Proteon Therapeutics, Inc.

This report analyzes the worldwide markets for Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics in US$ Million. The report provides separate comprehensive analytics for ...

... an inclusive study of the global CAR T cell therapy market. The report provides the size of the global CAR T cell therapy market from 2017 and the ... and Celgene Corporation among others. The global CAR T cell therapy market has been segmented into: Global CAR T Cell Therapy Market: By Targeted Antigen HER1 HER2 ...

... of Global Oxygen Therapy Market: Global Oxygen Therapy Market, By Type Equipment for Oxygen source: i. Oxygen concentrators ii. Compressed oxygen cylinders/ Green tanks iii. Liquid oxygen systems iv. Hyperbaric oxygen therapy chamber Devices for Oxygen delivery i. Oxygen masks ...

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding E3 Ubiquitin Protein Ligase Mdm2 (Double Minute 2 Protein or Hdm2 or Oncoprotein Mdm2 or p53 Binding Protein Mdm2 or MDM2 or EC 6.3.2.) development landscape Develop and ...

... Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (Dardarin or LRRK2 or EC 2.7.11.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) development landscape Develop and design ...

... emitters. Based on technologies, the radiation therapy market is segmented into external radiation therapy technologies, internal radiation therapies and systemic radiation therapy technologies. External radiation therapy technologies are further segmented into ...

... effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) development landscape Develop and design ...

... circumstances where treatment options are inadequate. The global proton therapy market is set to experience favorable growth driven by ... this market is constrained by challenges such as high cost of proton therapy, stringent regulations and barriers to implementation. The report “Global Proton Therapy Market: ...

Global Infectious Disease Therapeutics Market: Global infectious disease therapeutics market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for infectious disease therapeutics is projected to reach US$ XX Mn by 2023. Infectious diseases are caused by ...

Global Stem Cell Therapy Market: Global stem cell therapy market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for stem cell therapy is projected to reach US$ XX Mn by 2023. Stem cell therapy involves use of stem cells to treat various diseases ...

... cost of proton radiation therapy and stringent regulatory procedures may hamper the global proton therapy market over the forecast period. Market Scope: Global Proton Therapy Market Global proton therapy market is segmented ...

The global cancer therapeutics market should reach $172.6 billion by 2022 from $121 billion in 2017 at a ... at a CAGR of 7.6% for the period 2017-2022. The stomach cancer segment of the global cancer therapeutics market is expected to grow from $8.2 billion in 2017 to $11.9 billion in 2022 ...

Global Extracorporeal Shock Wave Therapy (ESWT) Market: Global Extracorporeal Shock Wave Therapy (ESWT) market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for Extracorporeal Shock Wave Therapy projected to reach US$ XX Mn by 2023 ...

... . The Thrombotic Thrombocytopenic Purpura (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Thrombotic Thrombocytopenic Purpura and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

... Fibrosis Therapeutics Market & Forecast (2014 – 2024) 2. Global Cystic Fibrosis Therapeutics Market - Major Marketed Products Sales & Forecast (2012 - 2024) 3. Global Cystic Fibrosis Therapeutics Market - Pharmacological Class Sales & Forecast (2015 – 2021) 4. By Geography - Cystic Fibrosis Therapeutics ...

... 2017 to 2024. Based on geography, the North America aromatherapy market is segmented into 3 geographical regions, such as, U.S., Mexico, Canada North America aromatherapy market competition by top players including Young Living ...

... ’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Leber’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) and features dormant and discontinued projects. The guide covers therapeutics under ...

... releases. The Liver Fibrosis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Liver Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

... releases. The Cachexia (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Cachexia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

... releases. The Fibrosis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

... releases. The Dupuytren Contracture (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Dupuytren Contracture and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

... releases. The Hepatic - Colorectal Metastasis (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Hepatic - Colorectal Metastasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...